Navigation Links
EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimer's Disease
Date:7/14/2010

HONOLULU, July 14 /PRNewswire/ -- EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease (ICAD) results from its proprietary gamma-secretase modulator (GSM) pre-clinical study.  In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.

EVP-0015962 is a proprietary small molecule compound that belongs to a new generation of potential Alzheimer's drugs known as gamma-secretase modulators.  EVP-0015962 selectively inhibits the production of the toxic aggregated amyloid AB42 peptide without affecting the total amount of AB.  As EVP-0015962 does not affect other gamma secretase substrates required for normal function, such as Notch, it is predicted to slow the progression of Alzheimer's disease by reducing the disease-associated toxic AB42 species.

In its study, EnVivo was able to show that EVP-0015962 significantly reduced the production of total amyloid load as measured by plaque count, surface area and aggregated AB in the brains of transgenic mice after 12 months of daily oral administration.  In the same model, mice developed deficits in the hippocampal memory task known as contextual fear conditioning.  Chronic dosing with EVP-0015962 reversed these deficits returning the cognitive function to normal levels.  In addition, EVP-0015962 reduced the amount of brain inflammation associated with amyloid plaque buildup in these animals.

These findings demonstrate continued positive effects in transgenic Alzheimer's animals with EVP-0015962.  Given the multiple positive results from this and previous studies, EnVivo is confid
'/>"/>

SOURCE EnVivo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
2. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015  Organovo Holdings, Inc. (NYSE MKT: ... breakthrough 3D bioprinting technology, announced today that the company ... 2015 Healthcare Conference, to be held in ... Keith Murphy , Chairman and Chief Executive Officer, ... advances and partnerships. Details of the presentations ...
(Date:5/26/2015)... May 26, 2015  RXi Pharmaceuticals Corporation ... focused on discovering and developing innovative therapies ... ophthalmology, today announced that the Company,s President and ... present at the Jefferies 2015 Global Healthcare ... 11:30 a.m. EDT. Dr. Cauwenbergh will present ...
(Date:5/26/2015)... May 26, 2015 For the ... Quality of Life Throughout Europe, the Middle ... Astellas Pharma EMEA is celebrating its 10 ... through the historic merger of Japanese pharmaceutical companies Yamanouchi ... committed to turning science into value for patients through ...
Breaking Medicine Technology:Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 2Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 2RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 4Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4
... symptoms of ADHD, DURHAM, N.C., Sept. 10 ... stress has been shown to significantly reduce,symptoms of ... phase 3 clinical trial conducted by Addrenex,Pharmaceuticals., ... achieved statistically,significant improvement over placebo in reducing an ...
... combination of micronutrients superior to, current ,AREDS, standard ... -, HOUSTON, Sept. 10 A landmark ... a patented,combination of antioxidants and micronutrients, enabled patients ... in the study,s,placebo arm, who received the "AREDS-type" ...
Cached Medicine Technology:Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD 2Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD 3TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration 2TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration 3
(Date:5/26/2015)... 26, 2015 Surging to over 674,923 ... the leading online health and wellness sites, Consumer Health ... online community. It has proven to be a ... articles, watch videos, ask questions and interact with the ... the official Consumer Health Digest YouTube Channel has offered ...
(Date:5/26/2015)... Abington is pleased to announce ... practice with seven medical professionals, has joined Abington ... site in the United States to be recognized ... the National Committee for Quality Assurance. , Family ... sick care – including routine gynecology care and ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 3,000 senior ... to explore and debate the future of the connected ... Freer Logic’s steering wheel that can read a driver’s ... to control a driving simulator by mind alone just ... of Freer Logic said: “We are working on cognitive ...
(Date:5/26/2015)... CO (PRWEB) May 26, 2015 It ... diverse community foundation in Colorado. On Wednesday, May 13, ... ushered in a new era of community-based giving with ... Titled “Our Future in the Making,” the event celebrated ... The Denver Foundation to mobilize resources for good. , ...
(Date:5/26/2015)... 26, 2015 On May 26, 2015, My ... salesman and distributor Dwayne Windfall. At the start of the ... that has some unique characteristics with it, so could you ... Windfall replies saying, “I was reading the newspaper looking for ... they were looking for a person with hustle. I responded ...
Breaking Medicine News(10 mins):Health News:Consumer Health Digest Official YouTube Channel: A Reliable Source of Health Information 2Health News:Family Medicine, Geriatrics and Wellness Joins Abington Health Physicians 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2
... TUESDAY, May 22 (HealthDay News) -- Healthier lifestyles and better ... for Americans with diabetes between 1997 and 2006, especially ... government report shows. During that time, deaths from all ... deaths caused by heart disease and stroke in this group ...
... YORK (May 22, 2012) -- Up to half of all prostate ... "fusion" gene and formation of its unique protein -- but no ... Cornell Medical College researchers have found that in these cancer cells, ... known as a chromatin, is warped in such a way that ...
... MTV programs about teenage pregnancy -- "16 and Pregnant" and ... the shows glamorized teenage pregnancy, while supporters said they discouraged ... suggests they,re both right. The study, which will appear ... female students because of the high dropout rate associated with ...
... It,s quite common for a female song sparrow to stray ... door, but a new study shows that sleeping around can ... The American Naturalist, found that offspring conceived outside ... than within-pair offspring. The findings throw a monkey wrench into ...
... (HealthDay News) -- Colonoscopies helped doctors detect a high ... the screening for the first time, a new study ... made available to otherwise healthy elderly people who have ... Grand Rapids Medical Education Partners, and colleagues from Spectrum ...
... of Environmental Health Sciences (NIEHS), part of the National ... Research Program (SRP) at the University of California, San ... grant will fund continued research on the molecular and ... and other hazardous waste sites. It is the ...
Cached Medicine News:Health News:U.S. Sees Drop in Deaths Linked to Diabetes 2Health News:U.S. Sees Drop in Deaths Linked to Diabetes 3Health News:Scientists unravel role of fusion gene in prostate cancer 2Health News:Scientists unravel role of fusion gene in prostate cancer 3Health News:Scientists unravel role of fusion gene in prostate cancer 4Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 2Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 3Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:Colonoscopy May Detect Curable Cancer in Elderly: Study 2Health News:UC San Diego Superfund Research Program receives $15 million grant renewal 2
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
10 L, Bulk Recommended for 2, 5, 10 L pipettes....
... Theken eDISC is a revolutionary advancement in ... assess and manage their patients. The eDISC's ... the eDISC from 1st and 2nd generation ... loads of the lumbar spine, the eDISC ...
... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
Medicine Products: